6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
11m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
38m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Esperion Therapeutics Inc (NASDAQ:ESPR) — investor relations, events, news, and company updates on 6ix.

Latest News

Esperion to Report First Quarter 2026 Financial Results on May 7

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference

Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026

Financials

Revenue

$403.14 M

Market Cap

$670.28 M

EPS

-0.11

Community Chat

Ask AI